Clinical Trial Update: Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating monalizumab in combination with cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Monalizumab (monalizumab)

Snippet

Sponsor: Innate Pharma | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED